A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

501

Enrollment

INDUSTRY

Sponsor class

Stopped Please see Detailed Description for termination reason.

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: PD 0332334
DRUG: PD 0332334
DRUG: PD 0332334
DRUG: Paroxetine
DRUG: Placebo

Sponsor

Pfizer